These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25563991)

  • 21. Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ.
    Uehara M; McGrath MM; Ohori S; Solhjou Z; Banouni N; Routray S; Evans C; DiNitto JP; Elkhal A; Turka LA; Strom TB; Tullius SG; Winkler DG; Azzi J; Abdi R
    Nat Commun; 2017 Oct; 8(1):951. PubMed ID: 29038423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
    J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor beta (TGFβ) plays a crucial role in prolonging allograft survival in an allodepletion ("pruning") skin transplant model.
    Watson D; Zhang GY; Hu M; Wang YM; Fletcher J; Sartor M; Alexander SI
    Transpl Immunol; 2014 May; 30(4):168-77. PubMed ID: 24746800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo.
    Kishimoto K; Dong VM; Issazadeh S; Fedoseyeva EV; Waaga AM; Yamada A; Sho M; Benichou G; Auchincloss H; Grusby MJ; Khoury SJ; Sayegh MH
    J Clin Invest; 2000 Jul; 106(1):63-72. PubMed ID: 10880049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance.
    Li Y; Li XC; Zheng XX; Wells AD; Turka LA; Strom TB
    Nat Med; 1999 Nov; 5(11):1298-302. PubMed ID: 10545997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerated acute allograft rejection accompanied by enhanced T-cell proliferation and attenuated Treg function in RBP-J deficient mice.
    Fu T; Zhang P; Feng L; Ji G; Wang XH; Zheng MH; Qin HY; Chen DL; Wang WZ; Han H
    Mol Immunol; 2011 Feb; 48(5):751-9. PubMed ID: 21168915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of costimulatory molecules as targets for new immunosuppressives in transplantation.
    Kishimoto K; Dong VM; Sayegh MH
    Curr Opin Urol; 2000 Mar; 10(2):57-62. PubMed ID: 10785843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
    Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
    Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
    Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATP and T-cell-mediated rejection.
    Castillo-Leon E; Dellepiane S; Fiorina P
    Curr Opin Organ Transplant; 2018 Feb; 23(1):34-43. PubMed ID: 29120881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection.
    Lo YC; Lee CF; Powell JD
    Curr Opin Organ Transplant; 2014 Aug; 19(4):363-71. PubMed ID: 24991977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Braking bad: novel mechanisms of CTLA-4 inhibition of T cell responses.
    Krummey SM; Ford ML
    Am J Transplant; 2014 Dec; 14(12):2685-90. PubMed ID: 25387592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD28-Dependent CTLA-4 Expression Fine-Tunes the Activation of Human Th17 Cells.
    Krummey SM; Hartigan CR; Liu D; Ford ML
    iScience; 2020 Apr; 23(4):100912. PubMed ID: 32203908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on potentials and promises of T cell co-signaling molecules in transplantation.
    Mardomi A; Mohammadi N; Khosroshahi HT; Abediankenari S
    J Cell Physiol; 2020 May; 235(5):4183-4197. PubMed ID: 31696513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Programmed T cell differentiation: Implications for transplantation.
    Crepeau RL; Ford ML
    Cell Immunol; 2020 May; 351():104099. PubMed ID: 32247511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic allograft rejection: a fresh look.
    Wedel J; Bruneau S; Kochupurakkal N; Boneschansker L; Briscoe DM
    Curr Opin Organ Transplant; 2015 Feb; 20(1):13-20. PubMed ID: 25563987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upstream-downstream: CD28 cosignaling pathways and T cell function.
    Rudd CE
    Immunity; 1996 Jun; 4(6):527-34. PubMed ID: 8673699
    [No Abstract]   [Full Text] [Related]  

  • 39. Targeting co-stimulatory pathways: transplantation and autoimmunity.
    Ford ML; Adams AB; Pearson TC
    Nat Rev Nephrol; 2014 Jan; 10(1):14-24. PubMed ID: 24100403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging regulatory T cell dynamics and CTLA4-mediated suppression of T cell priming.
    Matheu MP; Othy S; Greenberg ML; Dong TX; Schuijs M; Deswarte K; Hammad H; Lambrecht BN; Parker I; Cahalan MD
    Nat Commun; 2015 Feb; 6():6219. PubMed ID: 25653051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.